|
|
Volumn 80, Issue 3, 1992, Pages 569-574
|
|
Development of iron-chelating agents for clinical use
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
3 HYDROXY 4 PYRIDONE DERIVATIVE;
CHELATING AGENT;
DEFERIPRONE;
DEFEROXAMINE;
DEFEROXAMINE MESYLATE;
DEFERRIFERRITHIOCIN;
FERRITIN;
PRODRUG;
PYRIDOXAL ISONICOTINOYLHYDRAZONE;
SIDEROPHORE;
AGRANULOCYTOSIS;
BLOOD TOXICITY;
DRUG ABSORPTION;
DRUG COST;
DRUG EFFICACY;
DRUG INFUSION;
DRUG METABOLISM;
DRUG SAFETY;
EDITORIAL;
ERYTHROCYTE TRANSFUSION;
HUMAN;
INTRAPERITONEAL DRUG ADMINISTRATION;
INTRAVENOUS DRUG ADMINISTRATION;
IRON CHELATION;
IRON METABOLISM;
IRON OVERLOAD;
LD 50;
LETHAL DOSE;
NONHUMAN;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
SUBCUTANEOUS DRUG ADMINISTRATION;
|
|
EID: 0026690420
PISSN: 00064971
EISSN: None
Source Type: Journal
DOI: 10.1182/blood.v80.3.569.bloodjournal803569 Document Type: Editorial |
|
Times cited : (81)
|
|
References (0)
|
